Table 2 Correlations between PLA2G7 and clinicopathological characteristics of DLBCL peripheral blood. (GCB: germinal centre B-cell like; IPI: international prognostic index; CR: complete response; B2m: Recombinant Human beta-2-Microglobulin; LDH: lactate dehydrogenase; BCL: B-cell lymphoma)
From: Identification of PLA2G7 as a novel biomarker of diffuse large B cell lymphoma
Characteristics | PLA2G7 expression | P-value | |
|---|---|---|---|
High,no.cases(≥1.46) | Low,no.cases(< 1.46) | ||
Age (years) | 0.477 | ||
  ≤ 54 | 14 | 16 |  |
  > 54 | 13 | 10 |  |
Gender | 0.206 | ||
 Female | 14 | 9 |  |
 Male | 13 | 17 |  |
stage | 0.107 | ||
 I–II | 5 | 10 |  |
 III–IV | 22 | 16 |  |
Subtype | 0.034 | ||
 GCB | 13 | 7 |  |
 Non-GCB | 14 | 19 |  |
IPI score | 0.467 | ||
 0–2 | 21 | 23 |  |
  > 3 | 6 | 3 |  |
CR after first-line chemotheray | 0.318 | ||
 yes | 14 | 17 |  |
 no | 13 | 9 |  |
A/B symptoms | 0.810 | ||
 A | 20 | 20 |  |
 B | 7 | 6 |  |
Low serum albumin | 0.005 | ||
 yes | 11 | 2 |  |
 no | 16 | 24 |  |
High serum B2m | 0.039 | ||
 yes | 19 | 11 |  |
 no | 8 | 15 |  |
High serum LDH | 0.335 | ||
 yes | 15 | 11 |  |
 no | 12 | 15 |  |
CD10 | 0.006 | ||
 positive | 15 | 5 |  |
 negative | 12 | 21 |  |
CD20 | 0.978 | ||
 positive | 26 | 25 |  |
 negative | 1 | 1 |  |
BCL-2 | 0.420 | ||
 positive | 25 | 22 |  |
 negative | 2 | 4 |  |
BCL-6 | 0.175 | ||
 positive | 24 | 19 |  |
 negative | 3 | 7 |  |